Grant Jeremy T. - 21 Dec 2023 Form 3 Insider Report for Theravance Biopharma, Inc. (TBPH)

Role
Director
Signature
/s/ Brett A. Grimaud, Attorney-in-Fact
Issuer symbol
TBPH
Transactions as of
21 Dec 2023
Net transactions value
$0
Form type
3
Filing time
26 Dec 2023, 18:06:25 UTC
Next filing
10 May 2024

No securities are beneficially owned.